ES2052496T3 - Sustancia que contiene anticuerpo especifico obtenida de huevos y metodo para su produccion y uso. - Google Patents
Sustancia que contiene anticuerpo especifico obtenida de huevos y metodo para su produccion y uso.Info
- Publication number
- ES2052496T3 ES2052496T3 ES86402595T ES86402595T ES2052496T3 ES 2052496 T3 ES2052496 T3 ES 2052496T3 ES 86402595 T ES86402595 T ES 86402595T ES 86402595 T ES86402595 T ES 86402595T ES 2052496 T3 ES2052496 T3 ES 2052496T3
- Authority
- ES
- Spain
- Prior art keywords
- specific antibody
- eggs
- production
- substance containing
- antibody obtained
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/861—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgG3, IgG4, IgA, or IgY
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Uso de un anticuerpo especfico producido a partir del huevo completo o la yema o albúmina de huevos puestos por gallinas que han sido inmunizadas frente a antígeno patógeno, siendo activo el citado anticuerpo especfico frente al antígeno, para preparar una composición farmacéutica inmunizante administrable por vía oral para proteger un animal de enfermedades infecciosas intestinales causadas por el citado antígeno patógeno.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP26410885 | 1985-11-25 | ||
JP61218859A JPH0753669B2 (ja) | 1985-11-25 | 1986-09-17 | 鶏卵からの特異的抗体含有材料およびその製造方法と用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2052496T3 true ES2052496T3 (es) | 1994-07-16 |
Family
ID=26522788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES86402595T Expired - Lifetime ES2052496T3 (es) | 1985-11-25 | 1986-11-21 | Sustancia que contiene anticuerpo especifico obtenida de huevos y metodo para su produccion y uso. |
Country Status (7)
Country | Link |
---|---|
US (1) | US5080895B1 (es) |
EP (1) | EP0225254B1 (es) |
AU (1) | AU600240B2 (es) |
CA (1) | CA1306946C (es) |
CH (1) | CH0225254H1 (es) |
DE (1) | DE3689717T2 (es) |
ES (1) | ES2052496T3 (es) |
Families Citing this family (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5130128A (en) * | 1982-06-03 | 1992-07-14 | Stolle Research & Development Corporation | Use of honey as vaccine |
US5601823A (en) * | 1989-10-31 | 1997-02-11 | Ophidian Pharmaceuticals, Inc. | Avian antitoxins to clostridium difficle toxin A |
US5719267A (en) | 1989-10-31 | 1998-02-17 | Ophidian Pharmaceuticals Inc. | Clostridial toxin disease therapy |
US5919665A (en) | 1989-10-31 | 1999-07-06 | Ophidian Pharmaceuticals, Inc. | Vaccine for clostridium botulinum neurotoxin |
US5736139A (en) * | 1989-10-31 | 1998-04-07 | Ochidian Pharmaceuticals, Inc. | Treatment of Clostridium difficile induced disease |
US5648468A (en) * | 1990-03-09 | 1997-07-15 | Spaulding; Glenn F. | Process for identifying sex associated egg proteins and methods for increasing the probability that the avian offspring will be the desired sex |
US5753228A (en) * | 1992-08-25 | 1998-05-19 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Method of treating parasitosis by the enteral administration of hyperimmune hen egg yolk antibodies |
US5585098A (en) * | 1993-11-23 | 1996-12-17 | Ovimmune, Inc. | Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants |
US5814316A (en) * | 1994-08-05 | 1998-09-29 | Wisconsin Alumni Research Foundation | Compound to mimick a naturally occurring peptide's effect |
AU708398B2 (en) * | 1994-08-05 | 1999-08-05 | Wisconsin Alumni Research Foundation | CCK antibodies used to improve feed efficiency |
HUT78048A (hu) | 1994-10-24 | 1999-07-28 | Ophidian Pharmaceuticals, Inc. | A C. difficile által okozott betegség kezelésére és megelőzésére szolgáló vakcina és antitoxin |
US6967088B1 (en) * | 1995-03-16 | 2005-11-22 | Allergan, Inc. | Soluble recombinant botulinum toxin proteins |
DE19518232A1 (de) * | 1995-05-12 | 1996-11-14 | Ruediger Dr Schade | Aviäre, vitelline, gegen Stützgewebe gerichtete Antikörper |
DE19548221C1 (de) * | 1995-12-22 | 1997-05-15 | Biotest Pharma Gmbh | Orale Anwendung von Immunglobulin-Präparationen zur Behandlung und Prophylaxe chronischer Schmerzzustände |
ATE266676T1 (de) | 1996-03-12 | 2004-05-15 | Ovogenix Immunpharma Gmbh | Verwendung von aviären, vitellinen, gegen hiv- antigene gerichteten antikörpern zur herstellung pharmazeutischer zubereitungen |
US5741489A (en) * | 1996-05-24 | 1998-04-21 | Anitox Corporation | Passively administered antibody that enhances feed conversion efficiency |
US5725873A (en) * | 1996-07-22 | 1998-03-10 | Wisconsin Alumni Research Foundation | Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein |
SE9701026D0 (sv) | 1997-03-20 | 1997-03-20 | Immun System Ims Ab | use of avian antibodies |
JP3430853B2 (ja) * | 1997-04-11 | 2003-07-28 | 株式会社ゲン・コーポレーション | 胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤 |
US7344713B1 (en) * | 1997-07-07 | 2008-03-18 | Pimentel Julio L | Decreased fat absorption with an anti-lipase antibody |
US6086878A (en) * | 1997-08-21 | 2000-07-11 | Dcv, Inc. | Method of increasing muscle protein and reducing fat in animals |
EP1007697B1 (en) * | 1997-08-22 | 2007-03-14 | University Of Guelph | Production of proteins in eggs |
US6861572B1 (en) | 1997-11-14 | 2005-03-01 | Origen Therapeutics, Inc. | Production of proteins in eggs |
US20050114916A1 (en) * | 1998-08-21 | 2005-05-26 | Etches Robert J. | Production of proteins in eggs |
US7129390B2 (en) * | 1997-10-16 | 2006-10-31 | Avigenics, Inc | Poultry Derived Glycosylated Interferon Alpha 2b |
US6803035B2 (en) * | 1998-05-08 | 2004-10-12 | Arkion Life Sciences | Anti-diarrheal and method for using the same |
US6395273B1 (en) | 1998-06-10 | 2002-05-28 | Promega Corporation | Prevention and treatment of inflammatory bowel disease |
US7618624B1 (en) | 1999-01-07 | 2009-11-17 | Anitox Corporation | Weight control using an anti-lipase antibody |
DE19910159A1 (de) * | 1999-02-26 | 2000-09-14 | Rosemarie Heis | Spezifische lgY-Eidotterantikörper, ihre Gewinnung und ihre Verwendung |
US6213930B1 (en) | 1999-03-15 | 2001-04-10 | Wisconsin Alumni Research Foundation | Method of using anti-phospholipase A2 antibodies to enhance growth or improve feed efficiency |
US7241443B1 (en) * | 1999-07-15 | 2007-07-10 | Camas Incorporated | Immunogen adherence inhibitor and method of making and using same |
US7238351B2 (en) * | 1999-07-15 | 2007-07-03 | Peter Nash | Immunogen adherence inhibitor directed to lactic acid producing organisms and method of making and using it |
WO2001072141A2 (en) | 2000-03-24 | 2001-10-04 | Trouw Nutrition Usa | Combination of plasma and hyperimmunized products for increased performance of weanlings |
CA2357685A1 (en) * | 2000-09-18 | 2002-03-18 | Chisolm Biological Laboratory, Llc | Transfer factor composition and process for producing same |
US6468534B1 (en) * | 2000-09-21 | 2002-10-22 | 4Life Research, Lc | Methods for obtaining transfer factor from avian sources, compositions including avian-generated transfer factor, and methods of use |
US6506413B1 (en) * | 2001-04-30 | 2003-01-14 | Joseph C. Ramaekers | Compositions for treating animal diseases and syndromes |
US20060073197A1 (en) * | 2004-05-20 | 2006-04-06 | Ramaekers Joseph C | Encapsulated transfer factor compositions and methods of use |
US20070128253A1 (en) * | 2005-04-13 | 2007-06-07 | Ramaekers Joseph C | Encapsulated transfer factor compositions and methods of use |
US20030003104A1 (en) * | 2001-07-02 | 2003-01-02 | John Mottola | Method for removal of pathogens from a localized environment |
AU2002246753B8 (en) * | 2001-12-28 | 2009-09-24 | Camas, Incorporated | Organism adherence inhibitor and method of making and using same |
US7534433B2 (en) * | 2002-06-06 | 2009-05-19 | Anitox Corporation | Method for improving body weight gain and feed conversion efficiency in animals |
AU2002313212A1 (en) * | 2002-06-13 | 2003-12-31 | Kabushiki Gaisha Tokaibiken | Tailor-made preparation and process for producing the same |
JP3995541B2 (ja) * | 2002-06-28 | 2007-10-24 | 株式会社ゲン・コーポレーション | 抗鶏コクシジウム症組成物 |
US7815943B2 (en) | 2002-08-22 | 2010-10-19 | 4Life Research, Lc | Cardiovascular therapy composition including transfer factor and therapeutic methods including use of the composition |
ES2371395T3 (es) * | 2003-02-19 | 2011-12-30 | Camas Incorporated | Inhibidor de adherencia de inmunógenos y procedimiento de preparación y uso del mismo. |
US9701737B2 (en) | 2003-02-19 | 2017-07-11 | Camas, Incorporated | Immunogen adherence and method of making and using same |
US6866868B1 (en) * | 2003-09-15 | 2005-03-15 | 4Life Research, Lc | Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions |
US7883701B2 (en) * | 2003-12-19 | 2011-02-08 | Wisconsin Alumni Research Foundation | Method for enhancing growth or increasing feed efficiency through reducing binding between endotoxin and its receptor in the gastrointestinal tract |
EP1765395B1 (en) * | 2004-04-16 | 2011-02-09 | The Governors of the University of Alberta | Anti-gluten egg yolk antibodies for the treatment of celiac disease |
CA2521156A1 (en) * | 2005-09-16 | 2007-03-16 | John Hare | Antibodies as growth promoting agents |
US20090053197A1 (en) * | 2006-06-14 | 2009-02-26 | Ramaekers Joseph C | Transfer Factor Compositions and Methods |
US9125874B2 (en) | 2007-11-30 | 2015-09-08 | The Ramaekers Family Trust | Administration of transfer factor for improving reproductive health |
US8802094B2 (en) * | 2006-10-25 | 2014-08-12 | Wisconsin Alumni Research Foundation | Method of reducing phosphate absorption by administering orally an IgY anti-intestinal sodium phosphate cotransporter type 2B antibody |
US20080102067A1 (en) * | 2006-10-25 | 2008-05-01 | Cook Mark E | Immunogenic composition |
AU2007309026B2 (en) | 2006-10-26 | 2013-09-12 | Aovatechnologies, Inc. | Methods of reducing phosphate absorption |
US8282928B2 (en) * | 2007-05-30 | 2012-10-09 | The Governors Of The University Of Alberta | Anti-gluten egg yolk antibodies for the treatment of celiac disease |
WO2008148149A1 (en) * | 2007-06-05 | 2008-12-11 | Anadis Ltd | Method of treatment or inhibition of enterovirus 71 infection |
US9388236B2 (en) * | 2007-07-09 | 2016-07-12 | Nestec Sa | Methods for reducing allergies caused by environmental allergens |
HUE032078T2 (en) | 2007-07-09 | 2017-08-28 | Nestec Sa | Procedure for reducing allergies caused by environmental allergens |
WO2009035494A2 (en) * | 2007-07-30 | 2009-03-19 | The Scripps Research Institute | Methods for producing anti-glycan antibodies, vaccines and methods for treating cancer or infectious disease |
WO2009039256A1 (en) * | 2007-09-18 | 2009-03-26 | Ramaekers Nutrition, Llc | Growth factor fraction compositions and methods |
EP2278984A4 (en) * | 2007-11-30 | 2013-02-27 | Ramaekers Family Trust | COMPOSITIONS AND METHODS FOR ENHANCING FERTILITY |
GB0820259D0 (en) * | 2008-11-05 | 2008-12-10 | Mars Inc | Composition |
MX2012012915A (es) | 2010-05-07 | 2013-05-06 | Camas Inc | Adherencia de inmunogeno y metodo para formar y utilizar el mismo. |
MX340019B (es) | 2010-11-23 | 2016-06-22 | Pantheryx Inc | Composiciones y metodos para el tratamiento en aplicaciones clinicas de amplio espectro, no diferenciadas o combinadas. |
DE102011006809A1 (de) | 2011-04-05 | 2012-10-11 | Freistaat Bayern vertreten durch die Julius-Maximilians-Universität Würzburg | Verwendung eines Mittels aus Antikörpern und/oder Insulin-like growth factor-Antagonisten |
MX338863B (es) | 2011-12-16 | 2016-05-01 | Inst Politecnico Nacional | Metodo de obtencion de extracto dializable de leucocitos. |
US11268951B2 (en) * | 2017-09-20 | 2022-03-08 | Charles River Laboratories International, Inc. | CHO host cell protein assay |
AU2022277767A1 (en) | 2021-05-17 | 2023-10-26 | Societe Des Produits Nestle Sa | Cat food supplements comprising an anti-fel-d1 molecule and an animal digest |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1007568A (en) * | 1973-12-13 | 1977-03-29 | Michael C. Attwell | Bovine immunoglobulin isolation process |
US4550019A (en) * | 1978-03-22 | 1985-10-29 | South Africa Inventions Development Corporation | Manufacture and use of fowl egg antibodies |
US4357272A (en) * | 1978-03-22 | 1982-11-02 | The South African Inventions Development Corporation | Recovering purified antibodies from egg yolk |
FR2489690A1 (fr) * | 1979-05-07 | 1982-03-12 | Coturnix | Procede d'obtention de la fraction ovomucoide et d'un extrait d'ovomucoide de l'oeuf de caille, produits ainsi obtenus et leur application a titre de medicament |
GB2057451B (en) * | 1979-09-05 | 1983-05-05 | South African Inventions | Immunological preparations comprising egg yolk antibodies |
US4284623A (en) * | 1979-11-09 | 1981-08-18 | Beck Lee R | Method of treating inflammation using bovine milk |
US4402938A (en) * | 1980-05-29 | 1983-09-06 | Impro Products, Inc. | Food and the method of extracting the same from colostrum and milk |
US4748018A (en) * | 1984-02-07 | 1988-05-31 | Stolle Research & Development Corp. | Method of passive immunization of mammals using avian antibody |
US4534971A (en) * | 1982-10-20 | 1985-08-13 | Regents Of The University Of Minnesota | Complexation of anthracycline and anthraquinone antibiotics by the apo riboflavin binding protein from eggs |
-
1986
- 1986-11-21 EP EP86402595A patent/EP0225254B1/en not_active Expired - Lifetime
- 1986-11-21 CH CH86402595.2T patent/CH0225254H1/xx unknown
- 1986-11-21 ES ES86402595T patent/ES2052496T3/es not_active Expired - Lifetime
- 1986-11-21 DE DE3689717T patent/DE3689717T2/de not_active Expired - Lifetime
- 1986-11-21 CA CA000523566A patent/CA1306946C/en not_active Expired - Lifetime
- 1986-11-25 AU AU65648/86A patent/AU600240B2/en not_active Expired
-
1991
- 1991-04-01 US US07679839 patent/US5080895B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CH0225254H1 (en) | 1998-09-15 |
AU6564886A (en) | 1987-05-28 |
US5080895A (en) | 1992-01-14 |
AU600240B2 (en) | 1990-08-09 |
CA1306946C (en) | 1992-09-01 |
EP0225254B1 (en) | 1994-03-16 |
EP0225254A2 (en) | 1987-06-10 |
EP0225254A3 (en) | 1989-04-26 |
DE3689717T2 (de) | 1994-10-20 |
DE3689717D1 (de) | 1994-04-21 |
US5080895B1 (en) | 1998-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2052496T3 (es) | Sustancia que contiene anticuerpo especifico obtenida de huevos y metodo para su produccion y uso. | |
Bartz et al. | Prevention of murine rotavirus infection with chicken egg yolk immunoglobulins | |
ES2061799T3 (es) | Nuevo preparado medicamentoso y procedimiento para su preparacion. | |
ES2057191T5 (es) | Metodo de produccion para una composicion que contiene proteinas. | |
PT714444E (pt) | Atenuacao de um epitopo imunodominante de um antigenio para utilizacao em vacinas e imunoterapias para plantas, animais e homens | |
Sudjarwo et al. | The potency of chicken egg yolk immunoglobulin (IgY) specific as immunotherapy to Mycobacterium tuberculosis infection | |
Ifrah et al. | The role of the bursa of Fabricius in the immune response to vaccinal antigens and the development of immune tolerance in chicks (Gallus domesticus) vaccinated at a very young age | |
Webster et al. | A new avian influenza virus from feral birds in the USSR: recombination in nature? | |
ATE35136T1 (de) | Neue benzisoselenazolone, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate. | |
ES2102368T3 (es) | Conjugado de vacuna para el tratamiento de las enfermedades de las aves. | |
SE7902742L (sv) | Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav | |
MX10428A (es) | Procedimiento para la preparacion de compuestos arilpiperazinil-alquilenfenil-p-heterociclicos y productos obtenidos mediante el mismo. | |
AR010794A1 (es) | Vacuna para la vacunacion in ovo de aves de corral contra la enfermedad newcastle y uso del virus de la enfermedad newcastle en la preparacion de dichavacuna | |
Klipper et al. | Maternal antibodies block induction of oral tolerance in newly hatched chicks | |
CARLSTRÖM | Appearance in Children's Sera of Substances Capable of Neutralizing Canine Distemper Virus 1: Preliminary Report | |
ATE237355T1 (de) | Biologisches produkt zur präventiven oder therapeutischen oralen verabreichung gegen parvovirosis im hund | |
DE69823638D1 (de) | Oralprodukt zur Prävention und Behandlung von ansteckender Gastroenteritis in Kälbern | |
DK157732C (da) | Fremgangsmaade til fremstilling af en inaktiveret kombinationsvaccine klar til administrering, aktiv mod newcastle-syge og aegproduktionsfald fremkaldt af adeno-lignende vira | |
Abou Elazab et al. | Prolonged suppression of chick humoral immune response by antigen specific maternal antibody | |
Moticka | Development of immunological competence in chickens | |
EP3362092A1 (en) | Manufacture and use of personalized hyperimmune egg in psoriasis treatment | |
ATE4626T1 (de) | Wachtelei-lyophilisat zum behandeln immunoallergischer krankheiten. | |
MX171572B (es) | Substancia que contiene anticuerpo especifico a partir de huevos y metodo de produccion y uso de la misma | |
Samadieh et al. | Demonstration of avian influenza-A virus in Iran by Immunodiffusion technique | |
ES491920A0 (es) | Procedimiento para la preparacion de medicamentos inmunobio-terapicos a partir de cepas microbiologicas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 225254 Country of ref document: ES |